PATTERNOX

Company Overview

Snapshot

Founded in September 2019 by Ofir Aharon, PATTERNOX operates with 1–10 employees. The company has raised $500,000 across one funding round. In February 2025, PATTERNOX was recognized with the First Prize by Migdal and Shark Tank.

Business overview

PATTERNOX LTD specializes in developing innovative imaging methods for detecting skin and lesion deformities. The company's core technology, Lateral Movements of Backscattered-light (LMB), identifies tissue distortions not visible through traditional color changes, revealing early indicators of skin cancer or cosmetic concerns. PATTERNOX operates within the Health Tech & Life Sciences sector, focusing on medical devices, diagnostics, and digital healthcare, serving markets across Europe, Asia, and the Americas.

Strategic signal

In February 2025, PATTERNOX received the First Prize by Migdal and Shark Tank. This recognition highlights the company's innovative approach to early skin cancer detection and cosmetic concern identification, signaling strong validation of its technology and potential for market disruption within the medical diagnostics and digital healthcare sectors.

Company Intelligence Q&A

What is PATTERNOX's primary innovation?

PATTERNOX developed an innovative imaging method called Lateral Movements of Backscattered-light (LMB), which detects tissue distortions below the skin surface that are not reliant on color changes, revealing early indicators of skin cancer or cosmetic issues.

When was PATTERNOX founded and by whom?

PATTERNOX was founded in September 2019 by Ofir Aharon, PhD. Electroptics.

What recognition did PATTERNOX receive in February 2025?

In February 2025, PATTERNOX received the First Prize by Migdal and Shark Tank.

Which product does PATTERNOX offer?

PATTERNOX offers a product named PatScope, which is currently in its beta stage.

What is the total capital raised by PATTERNOX?

PATTERNOX has raised a total of $500,000 across one funding round.